Skip to content
StockMarketAgent
Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

KOSDAQ/041960 stock hub

KOSDAQ/041960 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/041960is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
676.4B
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/041960
In the news

Latest news · KOSDAQ/041960

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.8P50 17.1P75 31.9
Trailing P/En/a
P25 12P50 23.1P75 39.5
ROE-11.7
P25 -17.1P50 0.7P75 8.5
ROIC2.3
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/041960 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
193
Groups with data
11
Currency
KRW
Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
161
Enterprise value
KRW 691.7B
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Medical - Pharmaceuticals
Isin
KR7041960006
Last refreshed
2026-05-10
Market cap
KRW 676.4B
Price
KRW 9,350
Price currency
KRW
Rev Per Employee
325,871,392.98x
Sector
Healthcare
Sic
2836
Symbol
kosdaq/041960
Website
https://www.komipharm.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-1.07%
EV Earnings
-95.95x
EV/EBITDA
144.14x
EV/FCF
-186.52x
EV/Sales
13.18x
FCF yield
-0.55%
P/B ratio
9.39x
P/S ratio
12.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
3.74%
EBITDA Margin
9.15%
Gross margin
32.23%
Gross Profit
KRW 16.9B
Gross Profit Growth
-21.83%
Gross Profit Growth Q
-19.69%
Gross Profit Growth3 Y
14.33%
Gross Profit Growth5 Y
4.92%
Net Income
KRW -7.2B
Net Income Growth Years
0%
Pretax Margin
-15.12%
Profit Margin
-13.74%
Profit Per Employee
KRW -44.8M
ROA
0.95
Roa5y
-0.82
ROCE
2.42
ROE
-11.67
Roe5y
-3.28
ROIC
2.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr10y
-11.38%
Cagr15y
0.77%
Cagr1y
48.69%
Cagr20y
8.14%
Cagr3y
10.29%
Cagr5y
-0.4%
EPS Growth Years
0
OCF Growth Q
-69.35%
Revenue Growth
-10.74x
Revenue Growth Q
-24.38x
Revenue Growth Years
0x
Revenue Growth3 Y
9.65x
Revenue Growth5 Y
7.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
KRW 0.41
Assets
KRW 133.9B
Cash
KRW 27.9B
Current Assets
KRW 68.5B
Current Liabilities
KRW 52.8B
Debt
KRW 40.7B
Debt EBITDA
KRW 8.48
Debt Equity
KRW 0.56
Debt FCF
KRW -10.97
Equity
KRW 72.1B
Interest Coverage
0.75
Liabilities
KRW 61.9B
Long Term Assets
KRW 65.4B
Long Term Liabilities
KRW 9.1B
Net Cash
KRW -12.8B
Net Cash By Market Cap
KRW -1.89
Net Debt EBITDA
KRW 2.66
Net Debt Equity
KRW 0.18
Tangible Book Value
KRW 67.9B
Tangible Book Value Per Share
KRW 947
WACC
5.97

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.3
Inventory Turnover
2.39
Net Working Capital
KRW 21.4B
Quick ratio
0.86
Working Capital
KRW 15.7B
Working Capital Turnover
KRW 3.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-1.32%
Dividend per share
KRW 0
Last Dividend
KRW 18.45

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-70.13%
1Y total return
48.65%
200-day SMA
7,108.7
3Y total return
34.18%
50-day SMA
8,790
50-day SMA vs 200-day SMA
50over200
5Y total return
-1.99%
All Time High
47,510.6
All Time High Change
-80.32%
All Time High Date
2016-09-09
All Time Low
249.7
All Time Low Change
3,644.19%
All Time Low Date
2004-06-28
ATR
506.3
Beta
0.32
Beta1y
0.73
Beta2y
0.62
Ch YTD
33.19
High
9,590
High52
10,790
High52 Date
2026-04-17
High52ch
-13.35%
Low
9,260
Low52
4,960
Low52 Date
2025-06-02
Low52ch
88.51%
Ma50ch
6.37%
Price vs 200-day SMA
31.53%
RSI
52.16
RSI Monthly
70.1
RSI Weekly
59.64
Sharpe ratio
0.89x
Sortino ratio
1.57
Total Return
-1.32%
Tr YTD
33.19
Tr15y
12.14%
Tr1m
20.8%
Tr1w
-3.81%
Tr3m
24.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
KRW 2B
Operating Income Growth
-68.34
Operating margin
3.74

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
43,938,992%
Net Borrowing
14,364,744,060
Shares Insiders
38.79%
Shares Institutions
3.14%
Shares Out
72,341,878
Shares Qo Q
0.49%
Shares Yo Y
1.32%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

56
MetricValue
Adjusted FCF
KRW -3.7B
Average Volume
444,782.6x
Bv Per Share
970.6
CAPEX
KRW -3.1B
Ch10y
-70.13
Ch15y
12.14
Ch1m
20.8
Ch1w
-3.81
Ch1y
48.65
Ch20y
377.9
Ch3m
24.67
Ch3y
34.18
Ch5y
-1.99
Ch6m
58.74
Change
0.86%
Change From Open
0.54
Close
9,270
Days Gap
0.32
Depreciation Amortization
2,838,306,600
Dollar Volume
1,632,248,200
Earnings Date
2026-04-02
EBIT
KRW 2B
EBITDA
KRW 4.8B
EPS
KRW -102
F Score
4
FCF
KRW -3.7B
FCF EV Yield
-0.54x
FCF Per Share
KRW -51.26
Financing CF
10,203,765,990
Fiscal Year End
December
Founded
1,972
Income Tax
KRW 92.7M
Investing CF
5,843,905,160
Is Primary Listing
1
Last Earnings Date
2025-11-13
Last Report Date
2025-12-31
Last Split Date
2023-08-17
Last Split Type
Forward
Ma150
7,538.3
Ma150ch
24.03%
Ma20
9,365
Ma20ch
-0.16%
Net CF
15,439,748,930
Open
9,300
Position In Range
27.27
Ppne
55,824,048,040
Price Date
2026-05-08
Price EBITDA
KRW 141
Ptbv Ratio
9.97
Relative Volume
0.39x
Revenue
52,465,294,270x
Tax By Revenue
0.18x
Tr20y
377.9%
Tr6m
58.74%
Volume
174,572
Z Score
4.12
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KOSDAQ/041960 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/041960 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+48.6%
S&P 500 1Y: n/a
3Y total return
+34.2%
S&P 500 3Y: n/a
5Y total return
-2.0%
S&P 500 5Y: n/a
10Y total return
-70.1%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/041960?

Insider, institutional, and short-interest positioning.

Institutional ownership
+3.1%
Share of float held by funds and institutions
Insider ownership
+38.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+1.3%
Negative means the company is buying back shares.
Technical

KOSDAQ/041960 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
52.2
Neutral momentum band
Price vs 200-day MA
+31.5%
50/200-day relationship not available
Beta (5Y)
0.32
Less volatile than the market
Sharpe ratio
0.89
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/041960

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/041960 stock rating?

kosdaq/041960 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/041960 analysis?

The full report lives at /stocks/kosdaq/041960/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/041960?

The latest report frames kosdaq/041960 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/041960 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.